![Mohammed Qatanani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 5 M $ au 31/07/2026
Dr. Mohammed Qatanani is a Chief Scientific Officer at Scholar Rock Holding Corp.
Dr. Qatanani was previously employed as a Vice President-Program & Alliance Management by Dyne Therapeutics, Inc. and a Director-Discovery Research by Alexion Pharmaceuticals, Inc. He received his undergraduate degree from American University of Beirut, a graduate degree from American University of Beirut and an MBA from Baylor College of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/02/2026 | 98 445 ( 0,09 % ) | 5 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Technique/Scientifique/R&D | 01/09/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
American University of Beirut
 American University of Beirut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
